These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21751544)

  • 1. [Successful treatment of Erdheim-Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review].
    Adam Z; Koukalová R; Sprláková A; Rehák Z; Cervinek L; Szturz P; Krejcí M; Pour L; Zahradová L; Moulis M; Prásek J; Chaloupka R; Hájek R; Mayer J
    Vnitr Lek; 2011 Jun; 57(6):576-89. PubMed ID: 21751544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].
    Adam Z; Řehák Z; Koukalová R; Bortlíček Z; Krejčí M; Pour L; Szturz P; Prášek J; Nebeský T; Adamová Z; Král Z; Mayer J
    Vnitr Lek; 2014; 60(5-6):499, 501-11. PubMed ID: 24974755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodality imaging showing complete cardiovascular involvement by Erdheim-Chester disease.
    Alharthi MS; Calleja A; Panse P; Appleton C; Jaroszewski DE; Tazelaar HD; Mookadam F
    Eur J Echocardiogr; 2010 Aug; 11(7):E25. PubMed ID: 20406735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
    Adam Z; Sprláková A; Rehák Z; Koukalová R; Szturz P; Krejcí M; Pour L; Zahradová L; Cervinek L; Kren L; Moulis M; Hermanová M; Mechl M; Prásek J; Hájek R; Král Z; Mayer J
    Klin Onkol; 2011; 24(5):367-81. PubMed ID: 22070019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
    Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erdheim-chester disease: a rare cause of interstitial lung disease].
    Krüger S; Krop C; Wibmer T; Pauls S; Mottaghy FM; Schumann C; Hombach V
    Med Klin (Munich); 2006 Jul; 101(7):573-6. PubMed ID: 16850173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease].
    Adam Z; Balsíková K; Pour L; Krejcí M; Svacina P; Dufek M; Kren L; Hermanová M; Moulis M; Vanícek J; Neubauer J; Mechl M; Prásek J; Stanícek J; Koukalová R; Hájek R; Mayer J
    Vnitr Lek; 2009 Dec; 55(12):1173-88. PubMed ID: 20070034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Erdheim-Chester disease with cladribine: a rational approach.
    Myra C; Sloper L; Tighe PJ; McIntosh RS; Stevens SE; Gregson RH; Sokal M; Haynes AP; Powell RJ
    Br J Ophthalmol; 2004 Jun; 88(6):844-7. PubMed ID: 15148234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Imaging features of osseous and extra-osseous involvement in Erdheim-Chester disease].
    Adib O; Baroth E; Perard L; Scoazec JY; Vervueren L; Aubé C; Willoteaux S
    J Radiol; 2011; 92(7-8):671-80. PubMed ID: 21819909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erdheim-Chester disease: a non-Langerhans cell histiocytosis. A clinical-case and review of the literature].
    Valentini D; Cappelli C; Mizzoni F; Noto C; Toscano D; Foco M; Trasimeni G
    Clin Ter; 2004 May; 155(5):205-8. PubMed ID: 15344569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erdheim-Chester histiocytosis - a rare differential diagnosis].
    Vogel-Claussen J; Ernemann U; Schwenzer N; Horger M
    Rofo; 2011 Apr; 183(4):319-22. PubMed ID: 21469056
    [No Abstract]   [Full Text] [Related]  

  • 13. Erdheim-Chester disease: multisystem involvement and management with interferon-alpha.
    Suzuki HI; Hosoya N; Miyagawa K; Ota S; Nakashima H; Makita N; Kurokawa M
    Leuk Res; 2010 Jan; 34(1):e21-4. PubMed ID: 19679354
    [No Abstract]   [Full Text] [Related]  

  • 14. Erdheim-Chester disease mimicking multiple meningiomas.
    Donaldson G; Bullock P; Monson JP
    Br J Neurosurg; 2010 Jun; 24(3):296-7. PubMed ID: 20465459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Erdheim-Chester disease initially mistaken for Ormond's disease.
    Loddenkemper K; Hoyer B; Loddenkemper C; Hermann KG; Rogalla P; Förster G; Buttgereit F; Hiepe F; Burmester GR
    Nat Clin Pract Rheumatol; 2008 Jan; 4(1):50-5. PubMed ID: 18172449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erdheim-Chester disease: a rare clinical presentation as multiple system atrophy.
    Chandran V; Pal PK; Moin A; Chickabasaviah YT; Ravishankar S; Panda S
    Mov Disord; 2009 Feb; 24(3):461-3. PubMed ID: 19235927
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of histiocytoses to imatinib mesylate: fire to ashes.
    Janku F; Amin HM; Yang D; Garrido-Laguna I; Trent JC; Kurzrock R
    J Clin Oncol; 2010 Nov; 28(31):e633-6. PubMed ID: 20733125
    [No Abstract]   [Full Text] [Related]  

  • 18. Erdheim-Chester disease: characteristics and management.
    Munoz J; Janku F; Cohen PR; Kurzrock R
    Mayo Clin Proc; 2014 Jul; 89(7):985-96. PubMed ID: 24814521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.
    Goyal G; Shah MV; Call TG; Litzow MR; Hogan WJ; Go RS
    JAMA Oncol; 2017 Sep; 3(9):1253-1256. PubMed ID: 28253394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent pericardial effusion as first manifestation of Erdheim-Chester disease].
    Lutz SZ; Schmalzing M; Vogel-Claussen J; Adam P; May AE
    Dtsch Med Wochenschr; 2011 Sep; 136(39):1952-6. PubMed ID: 21935854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.